AlphaMol Science made breakthrough in orphan GPCR new drug discovery
Recently, AlphaMol Science has made breakthrough in G protein-coupled receptors (GPCRs) new drug discovery for several orphan receptors which have neither experimental structure nor active compound ever before. The "me-only" lead compounds have been obtained within 4 months which usually take 2-3 years to achieve for a complete new target.
AlphaMol Science develops front-end AI based biological computing and cutting-edge bio-technologies to substantially speed up modern drug discovery. AlphaMol aims at challenging essential diseases in human health, especially in the signaling pathway of GPCRs.
AlphaMol Science develops front-end AI based biological computing and cutting-edge bio-technologies to substantially speed up modern drug discovery. AlphaMol aims at challenging essential diseases in human health, especially in the signaling pathway of GPCRs.